未登录

Z

Zhenlei Zhang

southern medical university - china

H指数:14

被引数:611

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Methyltransferase like 3 promotes thyroid folliculogenesis via coordinating cell differentiation and polarization

甲基转移酶样3通过协调细胞分化和极化促进甲状腺滤泡形成

Journal of Translational Internal Medicine

IF7.4

2026-02-010

PRE

Development of a theranostic tri-nuclear gadolinium(III) complex based on apoferritin for multitarget therapy of orthotopic glioma

基于apoferritin的诊疗一体化三核钆(III)配合物的开发，用于异位胶质瘤的多靶点治疗

chinese journal of chemistry

IF10.3

2025-09-040

PRE

Design of a theranostic Gd (III)-Cu (I) complex to inhibit growth and metastasis of triple-negative breast cancer

一种用于抑制三阴性乳腺癌生长和转移的诊疗用Gd(III)-Cu(I)配合物的设计

IF11

2025-01-090

PRE

Anticancer Tetranuclear Cu(I) Complex Catalyzes a Click Reaction to Synthesize a Chemotherapeutic Agent in situ to Achieve Targeted Dual-Agent Combination Therapy for Cancer

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

IF16.9

2024-10-311

PRE

Developing an Arene Binuclear Ruthenium(II) Complex to Induce Ferroptosis and Activate the cGAS-STING Pathway: Targeted Inhibiting Growth and Metastasis of Triple Negative Breast Cancer

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2024-10-220

PRE

Rational Design of a Hetero-multinuclear Gadolinium(III)-Copper(II) Complex: Integrating Magnetic Resonance Imaging, Photoacoustic Imaging, Mild Photothermal Therapy, Chemotherapy and Immunotherapy of Cancer

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2024-08-151

PRE

A novel Au(III) agent designed to inhibit tumor growth and metastasis through inducing immunogenic cell death

IF11

2024-07-221

PRE

Development of a Pt(II) compound based on indocyanine green@human serum albumin nanoparticles: integrating phototherapy, chemotherapy and immunotherapy to overcome tumor cisplatin resistance

IF11

2024-06-261

OA

Proteostatic reactivation of the developmental transcription factor TBX3 drives BRAF/MAPK-mediated tumorigenesis ( vol 15 , 4108 , 2024)

NATURE COMMUNICATIONS

IF15.7

2024-06-100

OAAI

Proteostatic reactivation of the developmental transcription factor TBX3 drives BRAF/MAPK-mediated tumorigenesis

NATURE COMMUNICATIONS

IF15.7

2024-05-152

OAAI

miR-22 promotes stem cell traits via activating Wnt/β-catenin signaling in cutaneous squamous cell carcinoma

IF7.3

2023-11-170

OAAI

Combining hyperspectral imaging techniques with deep learning to aid in early pathological diagnosis of melanoma

PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY

IF2.6

2023-09-015

PRE

miR-22 promotes immunosuppression via activating JAK/STAT3 signaling in cutaneous squamous cell carcinoma

IF2.9

2023-07-194

PRE

Degradation, isomerization and stabilization of three dicaffeoylquinic acids under ultrasonic treatment at different pH

ULTRASONICS SONOCHEMISTRY

IF9.7

2023-05-0110

OAAI

CX-5461-inspired monofunctional platinum RNA polymerase I selective inhibitors with selective lethality in BRCA1-deficient cancer cells

INORGANIC CHEMISTRY FRONTIERS

IF6.4

2023-01-013

PRE

Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors (vol 13, 1588, 2022)

NATURE COMMUNICATIONS

IF15.7

2022-11-171

OAAI

Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors

NATURE COMMUNICATIONS

IF15.7

2022-03-2446

OAAI

miR-22 promotes stem cell traits via activating Wnt/beta-catenin signaling in cutaneous squamous cell carcinoma (vol 40, pg 5799, 2021)

IF7.3

2022-02-040

OAAI

miR-22 promotes stem cell traits via activating Wnt/β-catenin signaling in cutaneous squamous cell carcinoma

IF7.3

2021-08-0326

OAAI

A high performance 2-hydroxynaphthalene Schiff base fluorescent chemosensor for Al3+ and its applications in imaging of living cells and zebrafish in vivo

SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY

IF4.6

2019-01-0168

PREAI